title: Further evidence that naloxone acts as an inverse opiate agonist: implications for drug dependence and withdrawal.
abstract: To test if naloxone behaved as an inverse agonist rather than as an antagonist we evaluated its responses in guinea-pig ilea with and without morphine (480 nM, 24 h). In control ilea, naloxone (100 nM) had no effect. In morphine-treated ilea, naloxone as a bolus, but not as an infusion, elicited an abstinence response. Preadministration of naloxone blocked the response to subsequent administrations. Similarly, naloxone failed to produce an abstinence response in ilea pretreated with kappa compounds (bremazocine, U50488 or xorphanol 100 nM) or with kinase inhibitors (H7 or H8 30 microM). These findings can be interpreted in the light of the two-state receptor model if naloxone behaves as an inverse agonist: Incubation with morphine increased the active state of receptors making them susceptible to the inverse agonist (naloxone); exposure to naloxone favored the inactive conformation making them insensitive to further administration of naloxone; kappa compounds behaved as antagonists preventing the response to naloxone; and kinase inhibitors interfered with the active conformation making the system insensitive to naloxone. According to this model, dependence can be viewed as an overexpression of the active receptors and withdrawal as an abrupt change from the active to the inactive state.
authors.affiliation: Sección de Terapéutica Experimental, CINVESTAV, IPN, México DF, México.
authors.forename: S L
authors.initials: SL
authors.lastname: Cruz
authors.forename: J E
authors.initials: JE
authors.lastname: Villarreal
authors.forename: N D
authors.initials: ND
authors.lastname: Volkow
mesh_terms: D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; D000818:Animals; D006168:Guinea Pigs; D007082:Ileum / Q000187:drug effects / Q000502:physiology; D066298:In Vitro Techniques; D007546:Isoquinolines / Q000494:pharmacology; D009021:Morphine Dependence / Q000209:etiology*; D009270:Naloxone / Q000494:pharmacology*; D009292:Narcotic Antagonists / Q000494:pharmacology*; D010879:Piperazines / Q000494:pharmacology; D011957:Receptors, Opioid / Q000819:agonists*; D013375:Substance Withdrawal Syndrome / Q000209:etiology*
chemical_list: D007546:Isoquinolines; D009292:Narcotic Antagonists; D010879:Piperazines; D011957:Receptors, Opioid; D009270:Naloxone; D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine